CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsLow earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.78BCNY560.86M · vs all stocks (USD)
Revenue (TTM)
543.82MCNY80.77M · vs all stocks (USD)
Profit Margin
-44.20%Beta
-0.3280xvs all stocks
52-Week Change
-43.13%vs all stocks
Market Capitalization
3.78BCNY560.86M · vs all stocks (USD)
Enterprise Value
3.61BCNY536.57M · vs all stocks (USD)
Price to Sales (TTM)
7.31xPrice to Book (MRQ)
1.86xEnterprise to Revenue
6.64xEnterprise to EBITDA
-53.46xGross Margin
38.47%Profit Margin
-44.20%Operating Margin
-10.09%Return on Assets (TTM)
-3.77%Return on Equity (TTM)
-10.78%Revenue (TTM)
543.82MCNY80.77M · vs all stocks (USD)
Revenue per Share (TTM)
4.15CNYUpdated Aug 19, 2026Quarterly Revenue Growth
1.50%Gross Profit (TTM)
208.86MCNY31.02M · vs all stocks (USD)
EBITDA (TTM)
-67.58MCNY-10.04M · vs all stocks (USD)
Net Income (TTM)
-240.38MCNY-35.70M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-19.67%Operating Cash Flow (TTM)
-29.26MCNY-4.35M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-410.36MCNY-60.95M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
8.87MCNYFY2025 · Dec 31, 2025Revenue
541.45MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
310.57MCNYFY2025 · Dec 31, 2025Gross Profit
230.88MCNYFY2025 · Dec 31, 2025Operating Income
-121.77MCNY-18.08M · vs all stocks (USD)
Pre-tax Income
-238.76MCNYFY2025 · Dec 31, 2025Income Tax Expense
-3.33MCNYFY2025 · Dec 31, 2025Net Income
-235.43MCNYFY2025 · Dec 31, 2025EBIT
-237.37MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-2.32MCNYFY2025 · Dec 31, 2025Research & Development
88.24MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
176.65MCNYFY2025 · Dec 31, 2025Other Operating Expenses
8.10MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.41MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.39MCNYFY2025 · Dec 31, 2025EPS (Basic)
-1.77CNYFY2025 · Dec 31, 2025EPS (Diluted)
-1.77CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
130.66MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
130.66MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-235.43MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
4.16MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-231.85MCNYFY2025 · Dec 31, 2025Free Cash Flow
-281.01MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
648.24MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-235.43MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.88MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-8.71MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
8.41MCNYFY2025 · Dec 31, 2025Capital Expenditures
-49.17MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.27BCNYFY2025 · Dec 31, 2025Sale of Investments
1.65BCNYFY2025 · Dec 31, 2025Other Investing Activity
-971.64KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
332.92MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-4.96MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-17.87MCNYFY2025 · Dec 31, 2025Other Financing Charges
-4.42MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-27.26MCNYFY2025 · Dec 31, 2025Shares Outstanding
130.89MSharesUpdated Aug 19, 2026Float Shares
72.36MSharesUpdated Aug 19, 2026% Held by Insiders
44.70%vs all stocks
% Held by Institutions
2.61%vs all stocks
Total Cash (MRQ)
423.52MCNY62.90M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.24CNYUpdated Aug 19, 2026Total Debt (MRQ)
55.67MCNY8.27M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0260xCurrent Ratio (MRQ)
4.17xBook Value per Share (MRQ)
16.33CNYUpdated Aug 19, 2026Total Assets
2.58BCNY382.67M · vs all stocks (USD)
Total Current Assets
1.23BCNYFY2025 · Dec 31, 2025Total Liabilities
407.14MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.35BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
98.30MCNYFY2025 · Dec 31, 2025Total Current Liabilities
308.85MCNYFY2025 · Dec 31, 2025Cash
648.24MCNYFY2025 · Dec 31, 2025Cash Equivalents
84.64KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
648.33MCNYFY2025 · Dec 31, 2025Other Short-term Investments
170.63MCNYFY2025 · Dec 31, 2025Accounts Receivable
62.16MCNYFY2025 · Dec 31, 2025Inventory
82.94MCNYFY2025 · Dec 31, 2025Accounts Payable
33.13MCNYFY2025 · Dec 31, 2025Short-term Debt
67.07MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.65MCNYFY2025 · Dec 31, 2025Long-term Debt
3.90MCNYFY2025 · Dec 31, 2025Common Stock (Book)
130.89MCNYFY2025 · Dec 31, 2025Retained Earnings
138.83MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.17BCNY322.20M · vs all stocks (USD)
52-Week Low
22.58CNYUpdated Aug 19, 202652-Week High
61.76CNYUpdated Aug 19, 202652-Week Change
-43.13%vs all stocks
Beta
-0.3280xvs all stocks
50-Day MA
26.22CNYUpdated Aug 19, 2026200-Day MA
31.01CNYUpdated Aug 19, 2026Avg 10-Day Volume
10.08MSharesUpdated Aug 19, 2026Avg 30-Day Volume
9.85MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-1.84CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.59
Altman Z-Score 5.98: safe zoneNotable
Altman Z-Score: 5.98
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shandong Sinobioway Biomedicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shaanxi Kanghui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangsu Sihuan Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Careray Digital Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
CHA Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Boryung Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Assure Tech Hangzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Prime Medicine Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Orchid Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Botswana Diamonds plc
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Eagle High Plantations Tbk
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Ginkgo Bioworks Holdings Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated